Trials / Completed
CompletedNCT07100912
Human Skin Safety Testing of 6 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers
A Modified Draize Repeat Insult Patch Test in a Shared Panel of 100 Healthy Volunteers to Investigate the Irritation and Sensitization Potential of 6 Test Articles Following Repeated Cutaneous Patch Applications
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 113 (actual)
- Sponsor
- Amazentis SA · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to investigate the irritation and sensitization potential of 6 different topically applied test articles containing Mitopure in a shared panel of healthy volunteers by means of repeated cutaneous patch applications under occlusion based on the modified Draize method
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Mitopure Topical Formula 5 | Topical skin cream containing Mitopure |
| OTHER | Mitopure Topical Formula 6 | Topical skin cream containing Mitopure |
| OTHER | Mitopure Topical Formula 7 | Topical skin cream containing Mitopure |
| OTHER | Mitopure Topical Formula 8 | Topical skin serum containing Mitopure |
| OTHER | Mitopure Topical Formula 9 | Topical skin exfoliator containing Mitopure |
| OTHER | Mitopure Topical Formula 10 | Topical skin cleanser containing Mitopure |
Timeline
- Start date
- 2025-08-18
- Primary completion
- 2025-09-26
- Completion
- 2025-09-26
- First posted
- 2025-08-03
- Last updated
- 2025-11-17
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT07100912. Inclusion in this directory is not an endorsement.